Director Raman Chitkara of Arteris (AIP) sells 5,000 shares under 10b5-1 plan

Q: What insider transaction did Arteris (AIP) report for Raman Chitkara?

Arteris disclosed that director Raman Chitkara sold 5,000 shares of its common stock. The sale occurred on May 5, 2026 as an open-market transaction at a weighted average price of about $30.05 per share.

Q: At what price did Raman Chitkara sell Arteris (AIP) shares?

The reported price is a weighted average sale price of $30.0536 per share. According to the filing, the actual trade prices ranged from $30.00 to $30.26 per share across multiple transactions on the same day.

Q: How many Arteris (AIP) shares does Raman Chitkara own after this Form 4 sale?

Following the reported transaction, Raman Chitkara directly holds 142,867 shares of Arteris common stock. This figure reflects his position after selling 5,000 shares in the May 5, 2026 open-market transaction disclosed in the Form 4.

Q: Was the Arteris (AIP) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the transaction was made pursuant to a Rule 10b5-1 trading plan . That plan was adopted by the reporting person on March 7, 2025 , indicating the sale was pre-arranged rather than a spontaneous market decision.

Q: What does the weighted average price mean in the Arteris (AIP) Form 4?

The Form 4 lists a weighted average sale price of $30.0536 for the 5,000 shares. It explains these shares were sold in multiple trades between $30.00 and $30.26 , and detailed breakdowns are available upon request to the issuer or regulators.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Arteris, Inc. director Raman Chitkara sold 5,000 shares of Common Stock in an open-market transaction. The shares were sold on May 5, 2026 at a weighted average price of $30.0536 per share under a pre-arranged Rule 10b5-1 trading plan. After this sale, Chitkara directly holds 142,867 shares of Arteris common stock.

Insider Trade Summary 10b5-1

Net Seller: 5,000 shares ($150,268)

Net Sell 1 txn

Insider Chitkara Raman

Role null

Sold 5,000 shs ($150K)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,000	$30.0536	$150K

Holdings After Transaction: Common Stock — 142,867 shares (Direct, null)

Footnotes (1)

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 7, 2025. 2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.26 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 5,000 shares Weighted average sale price: $30.0536 per share Post-transaction holdings: 142,867 shares +1 more

4 metrics

Shares sold 5,000 shares Open-market sale on May 5, 2026

Weighted average sale price $30.0536 per share Common Stock sale on May 5, 2026

Post-transaction holdings 142,867 shares Shares directly owned after sale

Sale price range $30.00–$30.26 per share Range of individual trade prices

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open-market sale

3 terms

Rule 10b5-1 trading plan financial

"Transaction made pursuant to a 10b5-1 trading plan that was adopted..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 Insider Transactions: What Each Field Means →

05/07/2026 - 05:39 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chitkara Raman

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

CALIFORNIA

95008

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/05/2026		S⁽¹⁾		5,000	D	$30.0536⁽²⁾	142,867	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. 1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 7, 2025.

2. 2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.26 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Paul Alpern, as Attorney-in-Fact for Chitkara Raman	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Arteris (AIP) report for Raman Chitkara?

Arteris disclosed that director Raman Chitkara sold 5,000 shares of its common stock. The sale occurred on May 5, 2026 as an open-market transaction at a weighted average price of about $30.05 per share.

At what price did Raman Chitkara sell Arteris (AIP) shares?

The reported price is a weighted average sale price of $30.0536 per share. According to the filing, the actual trade prices ranged from $30.00 to $30.26 per share across multiple transactions on the same day.

How many Arteris (AIP) shares does Raman Chitkara own after this Form 4 sale?

Following the reported transaction, Raman Chitkara directly holds 142,867 shares of Arteris common stock. This figure reflects his position after selling 5,000 shares in the May 5, 2026 open-market transaction disclosed in the Form 4.

Was the Arteris (AIP) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the transaction was made pursuant to a Rule 10b5-1 trading plan. That plan was adopted by the reporting person on March 7, 2025, indicating the sale was pre-arranged rather than a spontaneous market decision.

What does the weighted average price mean in the Arteris (AIP) Form 4?

The Form 4 lists a weighted average sale price of $30.0536 for the 5,000 shares. It explains these shares were sold in multiple trades between $30.00 and $30.26, and detailed breakdowns are available upon request to the issuer or regulators.